Ying Shang

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (12)

Per Stal

Karolinska Institutet

SWEDEN

View details

Linnea Widman

Karolinska Institutet

SWEDEN

View details

Emilie Toresson Grip

Karolinska Institutet

SWEDEN

View details

Debora Rizzuto

Associate Professor

Karolinska Institutet

SWEDEN

View details

Anna-Karin Welmer

Karolinska University Hospital

SWEDEN

View details

jie guo

Karolinska Institutet

SWEDEN

View details

Hannes Hagström

Professor, Senior Consultant Hepatologist

Karolinska Institutet

SWEDEN

View details

Abigail Dove

Karolinska Institutet

SWEDEN

View details

Magnus Holmer

Karolinska University Hospital

SWEDEN

View details

Weili Xu

Karolinska Institutet

SWEDEN

View details

Stefano Romeo

SWEDEN

View details

Axel Wester

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ying Shang

Research Interests

Explore related searches

Contact this professor

Articles (16)

Risk of major adverse liver outcomes among first‐degree relatives of individuals with MASLD

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes

Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes

Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD

Risk of infections in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study

Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression

Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study

Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study

Healthy Behaviors, Leisure Activities, and Social Network Prolong Disability-Free Survival in Older Adults With Diabetes

Association between late-life weight change and dementia: A population-based cohort study.

Risk of cardiovascular disease and loss in life expectancy in NAFLD

Nonalcoholic Fatty Liver Disease and Risk of Dementia

Less is more? Screening for steatosis in older populations

Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER).

The impact of diabetes on cognitive impairment and its progression to dementia

Collaborators (12)

Per Stal

Linnea Widman

Emilie Toresson Grip

Debora Rizzuto

Anna-Karin Welmer

jie guo

Hannes Hagström

Abigail Dove

Magnus Holmer

Weili Xu

Stefano Romeo

Axel Wester

Make your next move.